

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical...
You can purchase shares of PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (OTCEM:PBLA) through any online brokerage.
There are no as such competitors for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..
PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. has a consensus price target of $25.00.
The stock price for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (OTCEM: PBLA) is $0.0001 last updated October 23, 2026 at 2:03 PM EDT.
There are no upcoming dividends for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..
PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..
PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine...